<ul><li>NVIDIA's BioNeMo Framework is being widely adopted by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.</li><li>The framework allows for scaling AI models, gathering insights from large datasets, and designing therapeutics faster.</li><li>The BioNeMo platform streamlines the entire AI drug discovery workflow and includes components like the BioNeMo Framework, NVIDIA NIM, and BioNeMo Blueprints.</li><li>Over 200 organizations, including Accenture, AWS, and Deloitte, are integrating BioNeMo into their drug discovery workflows.</li></ul>

NVIDIA BioNeMo Framework Accelerates AI Drug Discovery

Discover more